期刊
CLINICAL IMMUNOLOGY
卷 224, 期 -, 页码 -出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2020.108651
关键词
COVID-19; Comorbidities; Novel coronavirus; Preexisting condition; Severe outcome; SARS-CoV-2 outcome; Diabetes; Hypertension; Asthma; Cardiovascular diseases
类别
COVID-19 caused by SARS-CoV-2 can range from asymptomatic carriers to severe acute respiratory distress syndrome. Patients with comorbidities such as hypertension, diabetes, and chronic obstructive pulmonary disease are at higher risk of severe symptoms and poor prognosis.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndrome, sepsis, and death. As many as 50% of patients reported having at least one comorbidities with COVID-19 upon hospital admission. Hypertension, diabetes, chronic obstructive pulmonary disease, obesity, and cardiovascular diseases are among the most commonly reported. Comorbidities are contributing to acute disease prognosis and increased risk of severe symptoms. Around 70% of patients who require ICU care have been observed to have comorbidities. This review intends to understand how some of these comorbidities affect the disease's prognosis and how severe the outcome can be expected.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据